ASTRO 2026 Annual Meeting Press Kit

The 2026 ASTRO Annual Meeting — the leading global conference in radiation oncology — will be held September 26-30 at Boston’s Thomas M. Menino Convention & Exhibition Center. Led by ASTRO President Neha Vapiwala, MD, FASTRO, the meeting is organized around the theme, “Data to Dialogue: Communicating Radiotherapy's Value to Advance Care.” More than 2,500 abstracts, presented alongside educational panels, keynote addresses and other special programming, will explore the latest updates in radiation oncology, clinical trials results and patient care improvements. 

For additional details, view our media advisory, and find schedule and speaker details in the Annual Meeting Portal.

Press Registration

ASTRO provides complimentary meeting registration to credentialed news professionals representing media organizations for the sole purpose of gathering news and information to produce editorial coverage of the ASTRO Annual Meeting.

• Read more about eligibility for press registration.
• Submit your press registration here.

ASTRO will host an on-site press office in room 104C of the Thomas M. Menino Convention & Exhibition Center during meeting hours.

News Briefings

ASTRO news briefings will spotlight noteworthy and high-impact research presented at the meeting. Briefings will be held in room 104B of the convention center and via livestream.

Monday, September 28, 11:00 a.m. Eastern time

• A Randomized, Phase II Clinical Trial of Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Pancreatic Adenocarcinoma, the SOFT Preop Study (Abstract LBA 08), presented by William Hall, MD

• Alliance A071801 Phase III Trial Postoperative Single Fraction Stereotactic Radiosurgery (SRS) vs. Fractionated SRS (fSRS) for Resected Brain Metastasis (Abstract LBA 01), presented by Ayal Aizer, MD

• Efficacy of Radical Prostatectomy Versus Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Results from an international Phase III Randomized Controlled Trial (PACE–A) (Abstract LBA 32), presented by Nicholas van As, MD

• NRG-CC009: A Phase III Trial of Stereotactic Radiosurgery (SRS) vs. Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Brain Metastases from Small Cell Lung Cancer (SCLC) (Abstract LBA 02), presented by Chad Rusthoven, MD

• Phase II Multi-institutional Study of Ultralow-dose (4Gy) Response-adapted Radiotherapy for Symptomatic Bone Metastases from Multiple Myeloma (Abstract 10), presented by Leslie Ballas, MD, FASTRO

• Moderated by Beth Erickson, MD, FASTRO, incoming ASTRO President-elect

Tuesday, September 29, 9:00 a.m. Eastern time

• Endocrine Therapy Adherence after RT Omission in Estrogen Receptor-Positive Early-Stage Breast Cancer (Abstract 140), presented by Shannon Jiang, MD

• Radiosurgical Capsulotomy, a Novel Approach for Treatment-Resistant Major Depression: A Prospective Observational Study (Abstract 183), presented by Mohamed Khattab, MD

• Randomized Trial of Low-Dose Radiotherapy for Knee Osteoarthritis: Patient-Reported, Structural and Long-Term Clinical Endpoints (Abstract 4), presented by Nagendra (Bobby) Koneru, MD, FASTRO

• Role of Early Mental Health Interventions on Cancer Mortality for Patients with Depression (Abstract 195), presented by Edmund Qiao, MD

• Moderated by Farzan Siddiqui, MD, PhD, MBA, FASTRO, Vice Chair of the ASTRO Annual Meeting Scientific Committee

Embargo Policy and Access to Abstracts

All abstracts to be presented at the ASTRO Annual Meeting are embargoed until 5:00 p.m. Eastern time on Friday, September 25, 2026. For more details, view the full embargo policy. Contact ASTRO's media relations team with questions about the embargo policy or for press access to embargoed materials.

Abstracts will be available online via the Annual Meeting Portal when the embargo lifts. Abstracts also will be published and available at that time in the International Journal of Radiation Oncology • Biology • Physics (Red Journal). Abstract titles and presenter/presentation details are available now in the Annual Meeting portal. 

For More Information

For media inquiries, including interview requests, contact ASTRO’s media relations team.

Stay updated on ASTRO’s latest announcements via our social media channels.

For comprehensive, patient-focused radiation therapy and cancer resources, visit Speed of Light – The ASTRO Foundation.

For industry partners, guidelines on embargoes, press releases, media activities and social media are available here.

For additional meeting information, visit the ASTRO 2026 microsite.